ページを印刷する

肝胆膵外科 論文(2022年)

【英文論文】

原著論文

  1. Shimizu Y, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ohgi K, Otsuka S, Notsu A, Uesaka K. Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study. World J Surg. 2022 Jan;46(1):246-258.
  2. Nitta N, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Uesaka K. Differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green necessary to prevent post-hepatectomy liver failure associated with underlying diseases. Surg Today. 2022 Jan;52(1):36-45.
  3. Minagawa T, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Sasaki K, Uesaka K. Clinical implications of lymphadenectomy for invasive ductal carcinoma of the body or tail of the pancreas. Ann Gastroenterol Surg. 2022 Jan 18;6(4):531-542.
  4. Imamura T, Ohgi K, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Otsuka S, Tamura S, Uesaka K. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment. Pancreatology. 2022 Jun;22(5):636-643.
  5. Imamura T, Okamura Y, Ohshima K, Uesaka K, Sugiura T, Ito T, Yamamoto Y, Ashida R, Ohgi K, Otsuka S, Ohnami S, Nagashima T, Hatakeyama K, Kakuda Y, Sugino T, Urakami K, Akiyama Y, Yamaguchi K. Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation. Cancer Med. 2022 Apr;11(8):1769-1786.
  6. Yamamoto R, Sugiura T, Okamura Y, Ashida R, Ohgi K, Yamada M, Otsuka S, Aramaki T, Asakura K, Uesaka K. A novel method for predicting perineural invasion of distal cholangiocarcinoma on multidetector-row computed tomography. Surg Today. 2022 May;52(5):774-782.
  7. Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Aramaki T, Notsu A, Uesaka K. Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer Involving the Portal Vein: Is Pancreatic Body and/or Tail Cancer Involving the Portal Vein Resectable? Pancreas. 2022 May 1;51(5):502-509.
  8. Matsui S, Yamamoto Y, Okamura Y, Ito T, Ashida R, Ohgi K, Yamada M, Otsuka S, Uesaka K, Sugiura T. The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma. Anticancer Res. 2022 Jun;42(6):3169-3176.
  9. Terasaki F, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Yamada M, Otsuka S, Aramaki T, Uesaka K. Portal vein thrombosis after right hepatectomy: impact of portal vein resection and morphological changes of the portal vein. HPB (Oxford). 2022 Jul;24(7):1129-1137.
  10. Miura Y, Ohgi K, Sugiura T, Okamura Y, Ashida R, Yamada M, Otsuka S, Yasunaga Y, Nakagawa M, Uesaka K. Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surgery Justified? Ann Surg Oncol. 2022 Aug;29(8):4979-4988.
  11. Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. Ann Surg Oncol. 2022 Aug;29(8):4992-5002.
  12. Tezuka K, Ohgi K, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Otsuka S, Todaka A, Uesaka K. The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy. J Hepatobiliary Pancreat Sci. 2022 Aug;29(8):922-931.
  13. Shimizu Y, Ashida R, Sugiura T, Okamura Y, Ohgi K, Yamada M, Otsuka S, Aramaki T, Notsu A, Uesaka K. Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score. Ann Surg Oncol. 2022 Sep;29(9):5447-5457.
  14. Sano S, Okamura Y, Ohgi K, Sugiura T, Ito T, Yamamoto Y, Ashida R, Sasaki K, Uesaka K. Histological pancreatic findings correlate with computed tomography attenuation and predict postoperative pancreatic fistula following pancreatoduodenectomy. HPB (Oxford). 2022 Sep;24(9):1519-1526.
  15. Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, Aramaki T, Asakura K, Uesaka K. Preoperative risk factors for early recurrence after resection of perihilar cholangiocarcinoma. BJS Open. 2022 Sep 2;6(5):zrac115.
  16. Imamura T, Okamura Y, Ohshima K, Uesaka K, Sugiura T, Ito T, Yamamoto Y, Ashida R, Ohgi K, Otsuka S, Ohnami S, Nagashima T, Hatakeyama K, Sugino T, Urakami K, Akiyama Y, Yamaguchi K. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC Cancer. 2022 Oct 5;22(1):1046.
  17. Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, Okamura Y, Uesaka K. Converted-hepatopancreatoduodenectomy for an intraoperative positive ductal margin after pancreatoduodenectomy in distal cholangiocarcinoma. Langenbecks Arch Surg. 2022 Nov;407(7):2843-2852.
  18. Kubo H, Ohgi K, Ohike N, Tone K, Norose T, Sugiura T, Ashida R, Yamada M, Otsuka S, Uesaka K. Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer. Surgery. 2022 Dec;172(6):1776-1781.
  19. Ashida R, Yamamoto Y, Aramaki T, Sugiura T, Okamura Y, Ito T, Ohgi K, Uesaka K. Preoperative skeletal muscle fat infiltration is a strong predictor of poorer survival in gallbladder cancer underwent surgery. Clin Nutr ESPEN. 2022 Dec;52:60-67.
  20. Kasai S, Ashida R, Sugiura T, Ohgi K, Yamada M, Otsuka S, Kagawa H, Shiomi A, Kinugasa Y, Uesaka K. Long-term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single-center retrospective cohort study. Ann Gastroenterol Surg. 2022 Oct 5;7(2):318-325.
  21. Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas.
    Imamura T, Ashida R, Ohshima K, Uesaka K, Sugiura T, Okamura Y, Ohgi K, Ohnami S, Nagashima T, Yamaguchi K.
    Ann Gastroenterol Surg. 2022 Nov 27;7(3):491-502. doi: 10.1002/ags3.12636. eCollection 2023 May.
  22. Vascular resection for distal cholangiocarcinoma.
    Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, Aramaki T, Asakura K, Uesaka K.
    Surg Today. 2022 Dec 23. doi: 10.1007/s00595-022-02634-0. Online ahead of print.

症例報告

  1. Miura Y, Ashida R, Sugiura T, Ohgi K, Yamada M, Otsuka S, Todaka A, Uesaka K. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report. Surg Case Rep. 2022 Jan 26;8(1):20.
  2. Miura Y, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Sasaki K, Uesaka K. Granular cell tumor of the pancreas with chronic dilation of the main pancreatic duct. Clin J Gastroenterol. 2022 Oct;15(5):1006-1011.

【和文論文】

  1. 大木克久, 杉浦禎一, 蘆田　良, 山田美保子, 大塚新平, 上坂克彦. 十二指腸乳頭部癌に対する手術術式と適応. 外科. 2022, 84, 2, 149-152.
  2. 山田美保子，杉浦禎一，蘆田良，大木克久，大塚新平，石渡裕俊，新槇剛，上坂克彦. 特集　肝胆膵術後合併症―どう防ぐ？どう対処する？ 胆道・膵臓外科　胆管空腸吻合部縫合不全、狭窄. 臨床外科. 2022, 77, 3, 289-293.
  3. 大塚新平，杉浦禎一，蘆田良，大木克久，山田美保子，上坂克彦. 膵全摘（残膵全摘も含む）. 手術. 2022, 76, 4, 683-689.
  4. 大塚新平，杉浦禎一，蘆田良，大木克久，山田美保子，上坂克彦. 膵癌の術後補助化学療法. 医学と薬学. 2022, 79, 6, 765-769.
  5. 杉浦禎一，蘆田良，大木克久，山田美保子，大塚新平，上坂克彦. 肝門部領域胆管癌に対する外科治療 Up to date. 胆道. 2022, 36, 2, 151-157.
  6. 大塚新平，杉浦禎一, 蘆田良，大木克久，山田美保子，上坂克彦. 特集 胆膵周術期合併症のマネージメント　胆道再建を伴う肝切除後の難治性腹水に対するマネージメント. 胆と膵. 2022, 43, 9, 835-840.

肝・胆・膵外科

肝・胆・膵外科